CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by De Clercq & Partners against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Heterocyclic CompoundTAKEDA PHARMACEUTICALApr 10, 2025
Method Of Purifying PolypeptidesCSLJul 8, 2024
Method And System For Retarding Progression Of MyopiaTHE HONG KONG POLYTECHNIC UNIVERSITYMar 22, 2022
Perovskite Material Layer ProcessingHEE SOLARMay 31, 2021

Top competitors of De Clercq & Partners

List of top competitors of De Clercq & Partners based on patent oppositions.